{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:21:15Z","timestamp":1788459675002,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.toxicon.2026.109225","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:52:18Z","timestamp":1784789538000},"page":"109225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Safety and efficacy of recombinant botulinum toxin type A (Eveotox\u00ae) in patients with post-stroke upper limb spasticity: Results from a Phase Ib\/II clinical trial"],"prefix":"10.1016","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3227-7472","authenticated-orcid":false,"given":"Rongrong","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liandong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liayan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2026.109225_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.apmr.2019.01.016","article-title":"Effectiveness of botulinum toxin treatment for upper limb spasticity poststroke over different ICF domains: a systematic review and meta-analysis","volume":"100","author":"Andringa","year":"2019","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2026.109225_bib2","first-page":"179","article-title":"Post-stroke spasticity as a condition: a new perspective on patient evaluation","volume":"31","author":"Baricich","year":"2016","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.toxicon.2026.109225_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11599840-000000000-00000","article-title":"Clinical relevance of botulinum toxin immunogenicity","volume":"26","author":"Benecke","year":"2012","journal-title":"BioDrugs"},{"key":"10.1016\/j.toxicon.2026.109225_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","article-title":"Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke","volume":"347","author":"Brashear","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.toxicon.2026.109225_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/toxins13010058","article-title":"Botulinum toxin: an update on pharmacology and newer products in development","volume":"13","author":"Choudhury","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109225_bib6","article-title":"Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity","volume":"6","author":"Demetrios","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.toxicon.2026.109225_bib7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00415-018-8759-1","article-title":"Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy","volume":"265","author":"Dressler","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.toxicon.2026.109225_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/mus.24776","article-title":"Randomized, placebo-controlled trial of incobotulinumtoxinA for upper-limb post-stroke spasticity","volume":"53","author":"Elovic","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.toxicon.2026.109225_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.toxicon.2012.11.025","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome","volume":"67","author":"Esquenazi","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2026.109225_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/toxins10070278","article-title":"Engineering botulinum toxins to improve and expand targeting and SNARE cleavage activity","volume":"10","author":"Fonfria","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109225_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mds.30062","article-title":"Clinical outcome assessments for spasticity: review, critique, and recommendations","volume":"40","author":"Gal","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2026.109225_bib12","first-page":"411","article-title":"Five-step clinical assessment in spastic paresis","volume":"46","author":"Gracies","year":"2010","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"10.1016\/j.toxicon.2026.109225_bib13","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S1474-4422(15)00216-1","article-title":"Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial","volume":"14","author":"Gracies","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxicon.2026.109225_bib14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.apmr.2009.11.017","article-title":"Reliability of the tardieu scale for assessing spasticity in children with cerebral palsy","volume":"91","author":"Gracies","year":"2010","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2026.109225_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/toxins10050195","article-title":"Purification and characterization of recombinant botulinum neurotoxin serotype FA, also known as serotype H","volume":"10","author":"Hackett","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109225_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/toxins15050342","article-title":"Neutralizing antibody formation with onabotulinumtoxinA treatment from global registration studies across multiple indications: a meta-analysis","volume":"15","author":"Jankovic","year":"2023","journal-title":"Toxins"},{"issue":"5","key":"10.1016\/j.toxicon.2026.109225_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/WNF.0b013e3181b13308","article-title":"Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity","volume":"32","author":"Kanovsk\u00fd","year":"2009","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.toxicon.2026.109225_bib18","first-page":"9","article-title":"Test-retest reliability and inter-rater reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in hemiplegic patients with stroke","volume":"50","author":"Li","year":"2014","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"10.1016\/j.toxicon.2026.109225_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/STROKEAHA.109.558619","article-title":"Four-fold increase in direct costs of stroke survivors with spasticity compared with stroke survivors without spasticity","volume":"41","author":"Lundstr\u00f6m","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.toxicon.2026.109225_bib20","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s00415-020-09777-5","article-title":"Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE)","volume":"267","author":"Masakado","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.toxicon.2026.109225_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.rehab.2019.03.004","article-title":"Immunogenicity induced by botulinum toxin injections for limb spasticity: a systematic review","volume":"62","author":"Math\u00e9von","year":"2019","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"10.1016\/j.toxicon.2026.109225_bib22","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/PHM.0000000000000157","article-title":"Upper-limb spasticity during the first year after stroke: stroke arm longitudinal study at the University of Gothenburg","volume":"93","author":"Opheim","year":"2014","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2026.109225_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/pmrj.13258","article-title":"A randomized, double-blind, placebo-controlled trial of Daxibotulinumtoxin A for Injection for the treatment of upper limb spasticity in adults after stroke or traumatic brain injury","volume":"17","author":"Patel","year":"2025","journal-title":"PM R"},{"issue":"2","key":"10.1016\/j.toxicon.2026.109225_bib24","doi-asserted-by":"crossref","DOI":"10.2340\/16501977-2801","volume":"53","author":"Turner-Stokes","year":"2021","journal-title":"J. Rehabil. Med."},{"key":"10.1016\/j.toxicon.2026.109225_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.toxicon.2021.09.020","article-title":"The effectiveness of botulinum toxin on spasticity and gait of hemiplegic patients after stroke: a systematic review and meta-analysis","volume":"203","author":"Varvarousis","year":"2021","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2026.109225_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5999\/aps.2021.00766","article-title":"Immunogenicity of botulinum toxin","volume":"49","author":"Wee","year":"2022","journal-title":"Arch Plast Surg"},{"issue":"Suppl. 2","key":"10.1016\/j.toxicon.2026.109225_bib27","first-page":"S45","article-title":"Poststroke spasticity: sequelae and burden on stroke survivors and caregivers","volume":"80","author":"Zorowitz","year":"2013","journal-title":"Neurology"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010126002436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010126002436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:54:11Z","timestamp":1788458051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010126002436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":27,"alternative-id":["S0041010126002436"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2026.109225","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of recombinant botulinum toxin type A (Eveotox\u00ae) in patients with post-stroke upper limb spasticity: Results from a Phase Ib\/II clinical trial","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2026.109225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109225"}}